Loading clinical trials...
Loading clinical trials...
The classic Ph-negative myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic disorders caused by a dysregulated JAK/STAT signal transduction because of acquired somatic mutations of ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT07292246 · Breast Cancer, BRCA 1 Gene Mutation, and more
NCT02000089 · Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), and more
NCT06727383 · Healthy Donors, Myeloproliferative Diseases, and more
NCT01994057 · Non-small Cell Lung Cancer (NSCLC), EGFR-TKI Resistant Mutation, and more
NCT04585074 · Breast Neoplasms, Germline BRCA1 Gene Mutation, and more
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions